Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.

OBJECTIVE Cognitive-behavioral therapy (CBT) is a first-line treatment for panic disorder with agoraphobia (PD/AG). Nevertheless, an understanding of its mechanisms and particularly the role of therapist-guided exposure is lacking. This study was aimed to evaluate whether therapist-guided exposure in situ is associated with more pervasive and long-lasting effects than therapist-prescribed exposure in situ. METHOD A multicenter randomized controlled trial, in which 369 PD/AG patients were treated and followed up for 6 months. Patients were randomized to 2 manual-based variants of CBT (T+/T-) or a wait-list control group (WL; n = 68) and were treated twice weekly for 12 sessions. CBT variants were identical in content, structure, and length, except for implementation of exposure in situ: In the T+ variant (n = 163), therapists planned and supervised exposure in situ exercises outside the therapy room; in the T- group (n = 138), therapists planned and discussed patients' in situ exposure exercises but did not accompany them. Primary outcome measures were (a) Hamilton Anxiety Scale, (b) Clinical Global Impression, (c) number of panic attacks, and (d) agoraphobic avoidance (Mobility Inventory). RESULTS For T+ and T- compared with WL, all outcome measures improved significantly with large effect sizes from baseline to post (range = -0.5 to -2.5) and from post to follow-up (range = -0.02 to -1.0). T+ improved more than T- on the Clinical Global Impression and Mobility Inventory at post and follow-up and had greater reduction in panic attacks during the follow-up period. Reduction in agoraphobic avoidance accelerated after exposure was introduced. A dose-response relation was found for Time × Frequency of Exposure and reduction in agoraphobic avoidance. CONCLUSIONS Therapist-guided exposure is more effective for agoraphobic avoidance, overall functioning, and panic attacks in the follow-up period than is CBT without therapist-guided exposure. Therapist-guided exposure promotes additional therapeutic improvement--possibly mediated by increased physical engagement in feared situations--beyond the effects of a CBT treatment in which exposure is simply instructed.

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  Towards an Understanding of the Process and Mechanisms of Change in Cognitive Behavioral Therapy: Linking Innovative Methodology with Fundamental Questions. , 2007, Clinical psychology review.

[3]  H. Wittchen.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. , 1994, Journal of psychiatric research.

[4]  R. Royall.  Model robust confidence intervals using maximum likelihood estimators , 1986 .

[5]  J. Wolpe,et al.  Panic disorder: a product of classical conditioning. , 1988, Behaviour research and therapy.

[6]  Lars-Göran Öst,et al.  Cognitive behavior therapy vs exposure in vivo in the treatment of panic disorder with agrophobia , 2004 .

[7]  L. Robins.  THE COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW (CIDI) , 1994 .

[8]  A. Farmer,et al.  The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. , 1988, Archives of general psychiatry.

[9]  L. Castonguay,et al.  What is the scientific meaning of empirically supported therapy? , 1998, Journal of consulting and clinical psychology.

[10]  M. Antony,et al.  Exposure-Based Treatments for Anxiety Disorders: Theory and Process , 2008 .

[11]  Agoraphobia and Panic , 2008, Psychotherapy and Psychosomatics.

[12]  J. Endicott,et al.  Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH‐A) , 2001, Depression and anxiety.

[13]  Jasper A. J. Smits,et al.  Empirically supported treatments for panic disorder. , 2009, The Psychiatric clinics of North America.

[14]  D. Barlow,et al.  Social reinforcement in the modification of agoraphobia. , 1968, Archives of general psychiatry.

[15]  J. Margraf,et al.  Cognitive mediation of clinical improvement after intensive exposure therapy of agoraphobia and social phobia , 2010, Depression and anxiety.

[16]  P. McCullagh,et al.  Generalized Linear Models , 1992 .

[17]  M. Craske,et al.  Optimizing inhibitory learning during exposure therapy. , 2008, Behaviour research and therapy.

[18]  S. Hofmann,et al.  Panic control treatment and its applications. , 1999, The Journal of psychotherapy practice and research.

[19]  Joseph E LeDoux,et al.  Extinction Learning in Humans Role of the Amygdala and vmPFC , 2004, Neuron.

[20]  Kerry J Ressler,et al.  The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. , 2010, Clinics in laboratory medicine.

[21]  Virginia M. Bowden,et al.  Journal of Psychotherapy Practice and Research , 1993 .

[22]  Julio Sánchez-Meca,et al.  Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. , 2010, Clinical psychology review.

[23]  R. Kessler,et al.  The relationship of agoraphobia and panic in a community sample of adolescents and young adults. , 1998, Archives of general psychiatry.

[24]  M. Craske,et al.  Behavioral treatment of panic disorder: A two-year follow-up , 1991 .

[25]  Barbara O Rothbaum,et al.  Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. , 2004, Archives of general psychiatry.

[26]  Bunmi O. Olatunji,et al.  The Cruelest Cure? Ethical Issues in the Implementation of Exposure-Based Treatments , 2009 .

[27]  A. Gloster,et al.  Agoraphobia: a review of the diagnostic classificatory position and criteria , 2010, Depression and anxiety.

[28]  M. Craske,et al.  First-line Treatment : a Critical Appraisal of Cognitive Behavioral Therapy Developments and Alternatives Cognitive Behavioral Therapy Anxiety Disorders Exposure Mindfulness Efficacy , 2022 .

[29]  A. Gumley,et al.  Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland. , 2005, Health technology assessment.

[30]  A. Beck,et al.  Anxiety disorders and phobias : a cognitive perspective , 2005 .

[31]  J. Himle,et al.  Comparison of behavioral and cognitive-behavioral one-session exposure treatments for small animal phobias. , 2004, Behaviour research and therapy.

[32]  M K Shear,et al.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. , 2000, JAMA.

[33]  D. C. Richard,et al.  Chapter 1 8 – Exposure therapy has a public relations problem: A dearth of litigation amid a wealth of concern , 2007 .

[34]  A. Radomsky,et al.  Anxiety-control strategies: is there room for neutralization in successful exposure treatment? , 2008, Clinical psychology review.

[35]  Roz Shafran,et al.  Safety behaviour: a reconsideration. , 2008, Behaviour research and therapy.

[36]  A. Steiger,et al.  To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM‐IV disorders? Testing validity issues in a clinical sample , 1998 .

[37]  D. Westen,et al.  A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. , 2001, Journal of consulting and clinical psychology.

[38]  Linda B. Smith.  Cognition as a dynamic system: Principles from embodiment , 2005 .

[39]  Jasper A. J. Smits,et al.  DISORDERS : A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS , 2008 .

[40]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[41]  A. Gloster,et al.  Developments in the treatment and diagnosis of anxiety disorders. , 2009, The Psychiatric clinics of North America.

[42]  Mark B. Powers,et al.  Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis. , 2004, Journal of consulting and clinical psychology.

[43]  Murray B. Stein,et al.  Oxford handbook of anxiety and related disorders , 2008 .

[44]  E. Rüther,et al.  P.3.004 The application of the panic and agoraphobia scale (PAS) in clinical trials , 1997, European Neuropsychopharmacology.

[45]  E. Gracely,et al.  The Mobility Inventory for Agoraphobia. , 1985, Behaviour research and therapy.

[46]  M. Pollack,et al.  Empirically supported treatments for panic disorder: costs, benefits, and stepped care. , 2000, Journal of consulting and clinical psychology.

[47]  M. Craske,et al.  Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia. , 1997, The British journal of clinical psychology.

[48]  S. Williams,et al.  Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. , 1996, Behaviour research and therapy.

[49]  Mark B Powers,et al.  Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. , 2004, Journal of consulting and clinical psychology.

[50]  M. Höfler,et al.  Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[51]  G. Fava,et al.  Agoraphobia Is a Disease: A Tribute to Sir Martin Roth , 2008, Psychotherapy and Psychosomatics.

[52]  M. Bouton.  Context, ambiguity, and unlearning: sources of relapse after behavioral extinction , 2002, Biological Psychiatry.

[53]  D. Clark.  A cognitive approach to panic. , 1986, Behaviour research and therapy.

[54]  Mark B Powers,et al.  Fear activation and distraction during the emotional processing of claustrophobic fear. , 2004, Journal of behavior therapy and experimental psychiatry.

[55]  P. Schuster,et al.  Structure, Content and Reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) Substance Use Sections , 1998, European Addiction Research.